Clinical Efficacy of Jiaweisinisan on Chronic Superficial Gastritis with Liver-stomach Disharmony: A Clinical Observation
Hua Wang
Abstract
Hua Wang
Abstract
Objective: To observe the clinical effect of Jiaweisinisan( 加味四逆散) on Chronic superficial gastritis with liver-stomach disharmony. Methods: A randomized, open and controlled clinical trial design was applied; According to the ratio of 1:1, the 60 cases of patients with Chronic superficial gastritis with liver-stomach disharmony were randomly divided into treatment and control groups. Patients were treated by Jiaweisinisan in treatment group and Omeprazole Enteric-coated Cap-sules plus Domperidone Tablets in control groups and the treatment cours was 4 weeks. The change of syndrome was ob-served, as well as the recurrence. Results: The total effective rate was 96.7% in treatment group and 90.0% in control group,and there was no statistical difference(P0.05); the recurrence rate was 3.5% in treatment group and 25.9% in control group a month, and the treatment group showed lower recurrence than the control group( P 0.01). Conclusion: Jiaweisinisan can provide curative effect for Chronic superficial gastritis, relieve symptom and reduce the recurrence.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective: To observe the clinical effect of Jiaweisinisan( 加味四逆散) on Chronic superficial gastritis with liver-stomach disharmony. Methods: A randomized, open and controlled clinical trial design was applied; According to the ratio of 1:1, the 60 cases of patients with Chronic superficial gastritis with liver-stomach disharmony were randomly divided into treatment and control groups. Patients were treated by Jiaweisinisan in treatment group and Omeprazole Enteric-coated Cap-sules plus Domperidone Tablets in control groups and the treatment cours was 4 weeks. The change of syndrome was ob-served, as well as the recurrence. Results: The total effective rate was 96.7% in treatment group and 90.0% in control group,and there was no statistical difference(P0.05); the recurrence rate was 3.5% in treatment group and 25.9% in control group a month, and the treatment group showed lower recurrence than the control group( P 0.01). Conclusion: Jiaweisinisan can provide curative effect for Chronic superficial gastritis, relieve symptom and reduce the recurrence.
Key concepts: Medicine, Gastroenterology, Domperidone, Omeprazole, Stomach, Internal medicine, Gastritis, Chronic gastritis